You might like
Daily time spent on social media: 🇵🇭 Philippines: 4 hours 6 minutes 🇨🇴 Colombia: 3 hours 46 minutes 🇿🇦 South Africa: 3 hours 43 minutes 🇧🇷 Brazil: 3 hours 41 minutes 🇦🇷 Argentina: 3 hours 26 minutes 🇸🇦 Saudi Arabia: 3 hours 24 minutes 🇲🇽 Mexico: 3 hours 20 minutes 🇮🇩…
A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies. Syros on the radar of Big Pharma #StockToWatch #Stocktobuy marketwatch.com/amp/story/will…
52% of $SYRS is owned by the top healthcare institutions. #StocksInFocus #StockToWatch #Pennystocks money.cnn.com/quote/sharehol…
Flagship Pioneer (founded by founder of Moderna) major investor in $SYRS #StockToWatch #StockToBuy #Pennystocks flagshippioneering.com/companies
flagshippioneering.com
Companies
Flagship Pioneering is a a biotechnology company that invents platforms and builds companies that change the world.
$SYRS Oppenheimer target price $13 as of 3/2023 which is very recent. #StockToWatch #Stocktobuy #Pennystocks marketscreener.com/quote/stock/SY…
Where is big pharma going find growth and counter patents expiring? They’re going to micro biotech companies with multiple shots to succeed. Syros has 5 potential wins. Five studies all showing amazing results. #StocksToBuy #StockToWatch #Pennystocks
They get clyincally constructive on emerging biotech that has the ingedients of SYROS - deep proven experienced management team, compelling science and market opportunity, and balance sheets with verifiable cash runway - 2/2
Bain Life Sciences is one of the largest, smartest instututional investors in the biotech space. At last print they were long 2 million plus shares of SYROS in a highly slective portfolio of LS investments. That investment equates to 10 percent of SYROS's market cap. #Stocks 1/2
Everyone is watching and waiting for pop in Syros stock. Today is the day to buy and be a part of the run. Next data printout May 2023, is good or great, the stock price will accelerate to 10 plus dollars. IMO #StocksToBuy #stockstowatch #Pennystocks
Syros Pharmaceuticals A Buy Given Stock Price And Pipeline Potential (Rating Upgrade). Four indicators are showing a strong buy for $SYRS. #StockMarket #StockToWatch #stocktobuy
S3 are typically filed prior to big news being announced. Strategic move. $SYRS has a data printout coming in the next few weeks. Great opportunity right now to buy in prior to data printout. #StockMarket #stocktowatch #stocktobuy #Pennystocks
The average one-year price target for Syros Pharmaceuticals is $143.82 The forecasts range from a low of $13.13 to a high of $630.00. #StocksToBuy #StockToWatch #pennystocks
Analyzing Syros Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Syros Pharmaceuticals. 13 dollars per share after data printout in May 2023. #stockstowatch #StockToWatch #stocktobuy
Oppenheimer Adjusts Syros Pharmaceuticals Price Target to $13 From $15 in 2023. Maintains Outperform Rating. #stocktobuy #StockToWatch
Here is what the AI tool generated for The $SYRS stock: $SYRS is ranked#251 out of 4918 stocks and was rated STRONG BUY based on an Ai Algo Score of 722. $SYRS holds a Risk Score of 5 (1=Low Risk,10=High Risk). AI supports a $34.00 dollar stock price in 2023 #stocks #StockToWatch
Projected Stock Price for $SYRS $143.82 (4,662.25%) Estimated share price by March 15, 2024. #StocksToBuy #StockToWatch #pennystock #stocks
$SYRS Average earnings estimates for '23 are from 6 to 13$ #pennystocks #StockToWatch #StocksToBuy #StocksToTrade
Line chart with 4 lines. Source: Fintel.io The chart has 1 X axis displaying Date. Data ranges from 2022-03-21 00:00:00 to 2024-03-18 00:00:00. The chart has 1 Y axis displaying Share Price. Data ranges from 2.82 to 630. fintel.io/sfo/us/syrs?ut… 2/2 #StockToWatch
Monday Price Target The average one-year price target for Syros Pharmaceuticals is $143.82 The forecasts range from a low of $13.13 to a high of $630.00. Update Frequency: Monthly SYRS / Syros Pharmaceuticals Inc - 12 Month Price Target 1/2 #stocktobuy #StockToWatch
$SYRS has 240 millions in cash.That's will be enough to get them into 2025 . before that we'll have FDA approval and few more drugs in clinical trials.Relax everyone,this will be money milking cow. This will go at least to $30.this year 2023 #StockToWatch #stocktobuy #Pennystocks
![dogecoin's profile picture. Dogecoin is an open source peer-to-peer cryptocurrency, favored by shibas worldwide. Elon Musk thinks we're pretty cool. [RTs are not endorsements]](https://pbs.twimg.com/profile_images/378800000857919980/lHqPIZza.png)
United States Trends
- 1. Good Monday 26K posts
- 2. #MondayMotivation 30.9K posts
- 3. Happy Birthday Marines 3,387 posts
- 4. Rudy Giuliani 15K posts
- 5. Steelers 53.9K posts
- 6. Happy 250th 1,573 posts
- 7. #ITZY_TUNNELVISION 36.6K posts
- 8. Mr. 4 4,659 posts
- 9. 8 Democrats 11.1K posts
- 10. The BBC 422K posts
- 11. Resign 117K posts
- 12. Chargers 39K posts
- 13. Semper Fi 3,898 posts
- 14. #Talus_Labs N/A
- 15. Tomlin 8,441 posts
- 16. Tim Kaine 24.6K posts
- 17. 8 Dems 8,316 posts
- 18. Rodgers 21.8K posts
- 19. Dick Durbin 16K posts
- 20. Angus King 20.1K posts
You might like
Something went wrong.
Something went wrong.